RS57872B1 - Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom - Google Patents

Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom

Info

Publication number
RS57872B1
RS57872B1 RS20050737A RSP20050737A RS57872B1 RS 57872 B1 RS57872 B1 RS 57872B1 RS 20050737 A RS20050737 A RS 20050737A RS P20050737 A RSP20050737 A RS P20050737A RS 57872 B1 RS57872 B1 RS 57872B1
Authority
RS
Serbia
Prior art keywords
fsh
pharmaceutical formulations
ionic surfactant
liquid pharmaceutical
liquid
Prior art date
Application number
RS20050737A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Piergiorgio Donati
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33135521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS57872(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of RS57872B1 publication Critical patent/RS57872B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
RS20050737A 2003-04-02 2004-04-02 Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom RS57872B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02
EP03101543 2003-05-27
EP03101828 2003-06-20
PCT/EP2004/050432 WO2004087213A1 (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant

Publications (1)

Publication Number Publication Date
RS57872B1 true RS57872B1 (sr) 2018-12-31

Family

ID=33135521

Family Applications (2)

Application Number Title Priority Date Filing Date
YUP-2005/0737A RS20050737A (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant
RS20050737A RS57872B1 (sr) 2003-04-02 2004-04-02 Tečne farmaceutske formulacije fsh i lh zajedno sa nejonskim surfaktantom

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YUP-2005/0737A RS20050737A (en) 2003-04-02 2004-04-02 Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant

Country Status (25)

Country Link
US (1) US7741268B2 (sr)
EP (1) EP1610822B2 (sr)
JP (1) JP4699991B2 (sr)
KR (1) KR101105486B1 (sr)
AR (1) AR043972A1 (sr)
AT (1) ATE492292T2 (sr)
AU (1) AU2004226666B9 (sr)
BR (1) BRPI0409532B8 (sr)
CA (1) CA2518903C (sr)
CY (1) CY1111291T1 (sr)
DE (1) DE602004030673D1 (sr)
DK (1) DK1610822T4 (sr)
EA (1) EA012565B1 (sr)
HK (1) HK1086503A1 (sr)
HR (1) HRP20100727T4 (sr)
IL (1) IL171151A (sr)
ME (1) ME00217B (sr)
MX (1) MXPA05010635A (sr)
NO (1) NO330214B1 (sr)
NZ (1) NZ542247A (sr)
PL (1) PL1610822T5 (sr)
PT (1) PT1610822E (sr)
RS (2) RS20050737A (sr)
SI (1) SI1610822T2 (sr)
WO (1) WO2004087213A1 (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200640492A (en) * 2005-02-21 2006-12-01 Lg Life Sciences Ltd Sustained release composition of protein drug
TWI369401B (en) * 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
PL1951395T3 (pl) 2005-09-14 2012-08-31 Ares Trading Sa Sposób ilościowego oznaczania poloksamerów
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
EA019432B1 (ru) * 2007-11-01 2014-03-31 Мерк Сероно С.А. Жидкие композиции lh
DE202009009905U1 (de) 2008-02-08 2009-10-29 Biogenerix Ag Flüssig-Formulierung von FSH
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
CN102309747B (zh) * 2008-09-17 2013-04-17 上海天伟生物制药有限公司 高纯度绝经期促性腺素冻干针剂
RU2561057C2 (ru) * 2008-11-04 2015-08-20 Аска Фармасьютикал Ко., Лтд. Водная композиция, содержащая фолликулостимулирующий гормон
WO2010115586A2 (en) 2009-04-01 2010-10-14 Biogenerix Ag Method for purifying recombinant fsh
EP2325194A1 (en) 2009-11-24 2011-05-25 Glycotope GmbH Process for the purification of glycoproteins
WO2011076117A1 (zh) * 2009-12-22 2011-06-30 上海天伟生物制药有限公司 绝经期促性腺素组合物
WO2012127500A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for spermatogenesis
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN105658201A (zh) * 2013-11-12 2016-06-08 卡迪拉保健有限公司 促性腺激素的制剂
EP3145950B1 (en) * 2014-05-23 2019-01-09 Instituto Massone S.A. A process for obtaining hmg-up (human menopausal gonadotropin with ultra-purity grade) and a composition free of contaminants
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB839300A (en) 1957-09-05 1960-06-29 Organon Labor Ltd Adrenocorticotropic hormone preparations and process for making same
GB1065127A (en) 1963-03-11 1967-04-12 Serono Ist Farm Pituitary gonadotropic hormone preparation and method for its production
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4839341A (en) * 1984-05-29 1989-06-13 Eli Lilly And Company Stabilized insulin formulations
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
ES2051830T3 (es) * 1987-11-27 1994-07-01 Akzo Nv Solucion acuosa estable de anticuerpos.
US5096885A (en) 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5384132A (en) * 1990-03-20 1995-01-24 Akzo N.V. Stabilized gonadotropin containing preparations
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
DE4117078A1 (de) 1991-05-25 1992-11-26 Boehringer Ingelheim Kg Verfahren zur herstellung therapeutisch anwendbarer aerosole
EP0673383B1 (en) 1991-06-18 2000-05-31 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
IT1250075B (it) 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
IL106524A (en) 1992-07-31 2000-08-31 Genentech Inc Human growth hormone aqueous formulation
US5661125A (en) * 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
EP0682524B1 (en) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US6238890B1 (en) * 1994-02-18 2001-05-29 Washington University Single chain forms of the glycoprotein hormone quartet
CA2143044C (en) 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
US5580856A (en) * 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
ES2182920T3 (es) * 1994-12-22 2003-03-16 Ortho Pharma Corp Formulaciones solubles de 2-cloro02'-deoxiadenosina.
PT814778E (pt) * 1995-03-10 2001-11-30 Roche Diagnostics Gmbh Formas de administracao farmaceuticas contendo polipeptidos sob a forma de microparticulas e processo para a sua preparacao
JP2758154B2 (ja) 1995-04-06 1998-05-28 エフ・ホフマン−ラ ロシユ アーゲー インターフェロンを含む液体製剤
FR2733914B1 (fr) * 1995-05-11 1997-08-01 Sanofi Sa Composition de liquide stable contenant de l'urate oxydase et composition lyophilisee pour sa preparation
PT1516628E (pt) 1995-07-27 2013-09-24 Genentech Inc Formulação de proteína liofilizada isotónica estável
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
TR199800811T2 (xx) 1995-11-07 1998-07-21 Genentech,Inc. NGF i�in stabilize edici form�lasyonlar.
JP4672818B2 (ja) * 1996-12-23 2011-04-20 ノボ ノルディスク アクティーゼルスカブ 液体薬剤を貯蔵するための線状オレフィンのポリマーからなる薬剤容器
US6136784A (en) * 1997-01-08 2000-10-24 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
US7311912B1 (en) 1997-01-10 2007-12-25 Plantbodies Corporation Epithelial tissue targeting agent
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
US20010007673A1 (en) * 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6287587B2 (en) 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying
WO1999021534A1 (en) 1997-10-27 1999-05-06 Merck Patent Gmbh Solid state solutions and dispersions of poorly water soluble drugs
ZA9811127B (en) 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
PL346127A1 (en) * 1998-07-23 2002-01-28 Lilly Co Eli Fsh and fsh variant formulations, products and methods
US20020165146A1 (en) * 1998-07-23 2002-11-07 Hoffman James Arthur FSH article of manufacture
FR2782455B3 (fr) 1998-08-20 2000-09-15 Sanofi Sa Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine
BR9913857A (pt) * 1998-09-17 2001-06-12 Lilly Co Eli Formulações de proteìna
US6797483B1 (en) 1999-06-30 2004-09-28 Takeda Chemical Industries, Ltd. Polypeptide and DNA thereof
US6573237B2 (en) * 2001-03-16 2003-06-03 Eli Lilly And Company Protein formulations
AU2003217367B2 (en) 2002-02-08 2005-09-08 Alkermes Controlled Therapeutics, Inc. Polymer-based compositions for sustained release

Also Published As

Publication number Publication date
NZ542247A (en) 2008-03-28
AU2004226666B9 (en) 2010-04-08
SI1610822T1 (sl) 2011-02-28
IL171151A (en) 2014-11-30
RS20050737A (en) 2007-11-15
NO20054982L (no) 2005-10-26
CA2518903C (en) 2013-02-05
AU2004226666A1 (en) 2004-10-14
DE602004030673D1 (de) 2011-02-03
KR20050110037A (ko) 2005-11-22
DK1610822T4 (en) 2019-01-14
BRPI0409532A (pt) 2006-04-18
EP1610822A1 (en) 2006-01-04
HRP20100727T1 (en) 2011-02-28
NO330214B1 (no) 2011-03-07
HRP20100727T4 (hr) 2018-11-16
AU2004226666B2 (en) 2009-09-03
EP1610822B1 (en) 2010-12-22
KR101105486B1 (ko) 2012-01-13
ATE492292T2 (de) 2011-01-15
BRPI0409532B1 (pt) 2019-09-17
US20060147480A1 (en) 2006-07-06
DK1610822T3 (da) 2011-01-31
US7741268B2 (en) 2010-06-22
PL1610822T3 (pl) 2011-06-30
WO2004087213A8 (en) 2005-03-17
PT1610822E (pt) 2011-01-05
EA200501531A1 (ru) 2006-06-30
JP4699991B2 (ja) 2011-06-15
PL1610822T5 (pl) 2019-05-31
CA2518903A1 (en) 2004-10-14
WO2004087213A1 (en) 2004-10-14
BRPI0409532B8 (pt) 2021-05-25
CY1111291T1 (el) 2015-08-05
SI1610822T2 (sl) 2018-12-31
EA012565B1 (ru) 2009-10-30
AR043972A1 (es) 2005-08-17
EP1610822B2 (en) 2018-09-19
HK1086503A1 (en) 2006-09-22
MXPA05010635A (es) 2005-12-12
MEP31708A (en) 2010-10-10
ME00217B (me) 2011-02-10
JP2006522072A (ja) 2006-09-28

Similar Documents

Publication Publication Date Title
HRP20100727T4 (hr) Tekući farmaceutski pripravci fsh i lh zajedno s ne-ionskim surfaktantom
HK1066466A1 (en) Pharmaceutical formulations of antineoplastic agents in particular temozolomide processes of making and using the same
EP1438392A4 (en) CELL POPULATIONS EXPRESSING CD49C AND CD90
HK1102563A1 (en) Stabilized interferon liquid formulations
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
EP1747775A4 (en) DISPERSIBLE MONTMORILLONITE TABLET AND ITS MANUFACTURE
ZA200600099B (en) Active agents combination exhibiting insecticidal and acaricide properties
HUP0500610A3 (en) Indazoles, benzothiazoles, and benzoisothiazoles, pharmaceutical compositions comprises thereof and their uses
HK1082443A1 (en) Liquid transfusing tube and liquid transfusing tube set
EP1421775A4 (en) IN VIVO IMAGING DEVICE HAVING A SMALL TRANSVERSAL AREA AND METHODS OF CONSTRUCTION THEREOF
IL159359A0 (en) Aqueous buffered fluoride-containing etch residue removers and cleaners
AU2002301504A1 (en) Use of Non-spreading Silicone Surfactants in Agrochemical Compositions
HK1090324A1 (en) Suction device and nozzle device
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
PL1831414T3 (pl) Zastosowanie niejonowych środków powierzchniowo czynnych do otrzymywania metali
AP2005003382A0 (en) Liquid pharmaceutical formulations of palonosetron.
PT2327470E (pt) Elemento de bocal e sua utilização
EP1638513A4 (en) HIGHLY UNAVAILABLE CONNECTIONS AND METHOD OF USE THEREFOR
ZA200600098B (en) Active agents combination exhibiting insecticidal and acaricide properties
EP1646388A4 (en) INDENO AND CYTOTOXIC ISOINDOLOISOQUINOLONES
AU2003290345A1 (en) Pharmaceutical dissolution testing using a non-ionic surfactant
GB0404694D0 (en) Dolly and transportation using same
IL160781A0 (en) Use of lh in the manufacture of a medicament
GB0113182D0 (en) Mild antimicrbial liquid cleansing formulations
AU2002359945A1 (en) Nozzle and ejector